Education
About Us
Working with TipRanks
Follow Us
Hypha Labs (FUNI)
OTHER OTC:FUNI
FUNI Stock Chart & Stats
$0.04
>-$0.01(-17.23%)
At close: 4:00 PM EST
$0.04
>-$0.01(-17.23%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.04
Previous CloseN/A
Volume205.96K
Average Volume (3M)115.83K
Market Cap
$5.17M
Enterprise Value$6.65M
Total Cash (Recent Filing)$42.85K
Total Debt (Recent Filing)$1.75M
Price to Earnings (P/E)―
Beta1.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding162,521,820
10 Day Avg. Volume142,592
30 Day Avg. Volume115,825
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-1.47
Price to Sales (P/S)0.00
P/FCF Ratio-7.46
Enterprise Value/Market Cap1.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-4.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Cash-flow TrendTTM free cash flow remains negative but shows improvement versus the prior year, indicating management has reduced burn. That trend, if sustained, lowers near-term refinancing pressure and extends runway, offering a more durable path to stability while revenue remains absent.
Historical Path To ProfitabilityA prior profitable year demonstrates the business can achieve positive operating results under certain conditions. This suggests operational levers or market opportunities exist that could be scaled with disciplined execution, making profitability an achievable structural objective.
Lean Operating StructureA very small headcount implies low fixed payroll overhead and operational flexibility. Structurally, a lean team reduces cash required for operations, facilitates pivots, and preserves runway—helpful across multiple months while the company addresses commercialization and funding.
Bears Say
Zero Revenue Run-rateNo reported revenue in the trailing period indicates the company lacks recurring sales or commercial traction. Absent material product commercialization, the firm cannot organically fund operations, making sustained external financing or a strategic pivot necessary for long-term viability.
Negative Equity And Thin Asset BasePersistent negative shareholders' equity and minimal assets relative to obligations signal elevated solvency and refinancing risk. Over the medium term, this limits financial flexibility, raises creditor concerns, and increases the probability of dilutive or costly capital raises if losses continue.
Continued Cash BurnOngoing negative operating and free cash flows mean the company consumes resources each period. Structurally, sustained burn requires repeated external financing, constrains investment in product development or commercialization, and elevates execution and dilution risks over months.
Hypha Labs News
FUNI FAQ
What was Hypha Labs’s price range in the past 12 months?
Hypha Labs lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
What is Hypha Labs’s market cap?
Hypha Labs’s market cap is $5.17M.
When is Hypha Labs’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Hypha Labs’s earnings last quarter?
Currently, no data Available
Is Hypha Labs overvalued?
According to Wall Street analysts Hypha Labs’s price is currently Overvalued.
Does Hypha Labs pay dividends?
Hypha Labs does not currently pay dividends.
What is Hypha Labs’s EPS estimate?
Hypha Labs’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hypha Labs have?
Hypha Labs has 162,521,820 shares outstanding.
What happened to Hypha Labs’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hypha Labs?
Currently, no hedge funds are holding shares in FUNI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hypha Labs
Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. Hypha Labs, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
Technical Analysis
NovaBay Pharma
―
Aethlon Medical
―
Enveric Biosciences
―
Evaxion Biotech
―
SciSparc Ltd.
―